Evidence map›Paper›PMID 36647104›Full record

ArticleBMC health services research2023

Predictors of delayed Anti-Retroviral Therapy initiation among adults referred for HIV treatment in Uganda: a cross-sectional study.

Micheal Kiyingi, Joaniter I Nankabirwa, Christine Sekaggya-Wiltshire, Joan Nangendo, John M Kiweewa, Anne R Katahoire, Fred C Semitala

Open access · goldAbstract read
In one paragraph

Article in BMC health services research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Micheal KiyingiDepartment of Medicine, Makerere University College of Health Sciences, Makerere University, Box 7062, Kampala, Uganda. michealkiyingi@gmail.com.
Joaniter I NankabirwaDepartment of Medicine, Makerere University College of Health Sciences, Makerere University, Box 7062, Kampala, Uganda.
Christine Sekaggya-WiltshireInfectious Diseases Institute, Makerere University, Kampala, Uganda.
Joan NangendoDepartment of Medicine, Makerere University College of Health Sciences, Makerere University, Box 7062, Kampala, Uganda.
John M KiweewaEducation Department, Fairfield University, Fairfield, CT, USA.
Anne R KatahoireChild Health and Development Center, Makerere University, Kampala, Uganda.
Fred C SemitalaDepartment of Medicine, Makerere University College of Health Sciences, Makerere University, Box 7062, Kampala, Uganda.
Makerere University · UGInfectious Diseases Research Collaboration · UGFairfield University · US

Funding

Strengthening behavioral and social science research capacity to address the evolving challenges in HIV care and prevention in UgandaD43TW011304 · FIC · MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES · PI Carol Suzanne Camlin, MOSES Robert KAMYA · 2019 to 2026
$2.2M
FIC NIH HHS D43 TW011304
6 · The paper itself

Abstract

backgroundUganda's current guidelines recommend immediate initiation of Anti-Retroviral Therapy (ART) for persons living with HIV in order to reduce HIV/AIDS related morbidity and mortality. However, not all eligible PLHIV initiate ART within the recommended time following HIV diagnosis. We assessed the prevalence and factors associated with delayed ART initiation among PLHIV referred for ART initiation, five years since rolling out the test and treat guidelines.

methodsIn this cross-sectional study, we enrolled adult patients referred to Mulago Immune Suppressive Syndrome (Mulago ISS) clinic for ART initiation from January 2017 to May 2021. We collected data on socio-demographics, HIV diagnosis and referral circumstances, and time to ART initiation using a questionnaire. The outcome of interest was proportion of patients that delayed ART, defined as spending more than 30 days from HIV diagnosis to ART initiation. We performed multivariable logistic regression and identified significant factors.

resultsA total of 312 patients were enrolled of which 62.2% were female. The median (inter-quartile range [IQR]) age and baseline CD4 count of the patients were 35 (28-42) years and 315 (118.8-580.5) cells/μL respectively. Forty-eight (15.4%) patients delayed ART initiation and had a median (IQR) time to ART of 92 (49.0-273.5) days. The factors associated with delayed ART initiation were; 1) having had the HIV diagnosis made from a private health facility versus public, (adjusted odds ratio [aOR] = 2.4 (95% confidence interval [CI] 1.1-5.5); 2) initial denial of positive HIV test results, aOR = 5.4 (95% CI: 2.0-15.0); and, 3) having not received a follow up phone call from the place of HIV diagnosis, aOR = 2.8 (95% CI: 1.2-6.8).

conclusionThere was significant delay of ART initiation among referred PLHIV within 5 years after the rollout of test and treat guidelines in Uganda. Health system challenges in the continuity of HIV care services negatively affects timely ART initiation among referred PLHIV in Uganda.

Indexed as

Acquired Immunodeficiency SyndromeAnti-HIV AgentsHIV InfectionsAdultAntiretroviral Therapy, Highly ActiveCD4 Lymphocyte CountCross-Sectional StudiesFemaleHumansMaleUgandaAnti-HIV AgentsAnti-retroviral therapyInitiationPersons living with HIVPredictorsPrevalenceReferral

Identifiers

PMID36647104
PMCPMC9843953
OpenAlexW4316589738

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.